All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

ViewsDownloads

Relative Articles

More...
Health  2024 

Promoting Sickle Cell Trait Awareness and Education: A Typology of Interventions in the United States to Inform Ongoing Efforts to Patients and Providers

DOI: 10.4236/health.2024.164022, PP. 280-308

Keywords: Sickle Cell Trait Awareness, Sickle Cell Trait Messaging, Sickle Cell Trait Intervention, Typology, Scoping Review

Full-Text   Cite this paper   Add to My Lib

Abstract:

Research Background: Sickle cell trait has no treatment or cure and predominantly affects people who are Black, but can affect anyone of any race or ethnicity. While commonly incorrectly considered benign by providers and the public, people with a sickle cell trait experience life-threatening outcomes that are exacerbated by extreme conditions. There is a severe lack of awareness and understanding of sickle cell trait and the associated health complications among sickle cell trait carriers and healthcare providers. Purpose/Aim: Interventions that aim to improve awareness of sickle cell trait differ in approaches and are not well documented in the literature. This typology aims to highlight current efforts to inform targeted interventions that raise awareness through consistent messaging, educate people and providers on sickle cell trait and the related health complications, and support the design and implementation of comprehensive sickle cell trait awareness initiatives. Methods: We conducted a scoping review of United States-based sickle cell trait interventions and performed a content analysis to identify the categories and characteristics of these efforts. We then organized the results into a typology according to established protocols. Results: Among 164 interventions, twenty-five (15%) met the typology inclusion criteria described above and were grouped into categories: Seven of twenty-five interventions were Educational Interventions (28%), three of twenty-five interventions (12%) were Combined Screening and Educational-Based Interventions, eight of twenty-five interventions (32%) were Policy and Guideline-Based Intervention, and six of twenty-five interventions (24%) were Sickle Cell Trait Organization-Led Interventions. Conclusions: There is a lack of consistency in messaging across interventions whether delivered by credible healthcare institutions or national organizations, which can result in lack of education and awareness and confusion around sickle cell trait. Categorizing interventions through a typology allows clarity and informs consistency in messaging, which should be at the forefront of future sickle cell trait efforts.

References

[1]  Piel, F.B., et al. (2010) Global Distribution of the Sickle Cell Gene and Geographical Confirmation of the Malaria Hypothesis. Nature Communications, 1, Article No. 104.
https://doi.org/10.1038/ncomms1104
[2]  (2024) Sickle Cell Disease—Sickle Cell Trait.
https://www.nhlbi.nih.gov/health/sickle-cell-disease/sickle-cell-trait
[3]  Kotila, T.R. (2016) Sickle Cell Trait: A Benign State? Acta Haematologica, 136, 147-151.
https://doi.org/10.1159/000446526
[4]  (2023) Sickle Cell Trait Toolkit.
https://www.cdc.gov/ncbddd/sicklecell/toolkit.html
[5]  Msaouel, P., Rao, P. and Tannir, N.M. (2019) Renal Medullary Carcinoma. In: Malouf, G. and Tannir, N., Eds., Rare Kidney Tumors, Springer, Cham, 65-75.
https://doi.org/10.1007/978-3-319-96989-3_6
[6]  Kiryluk, K., Jadoon, A., Gupta, M. and Radhakrishnan, J. (2007) Sickle Cell Trait and Gross Hematuria. Kidney International, 71, 706-710.
https://doi.org/10.1038/sj.ki.5002060
[7]  Cochran Jr., R.T. (1963) Hyposthenuria in Sickle Cell States. The Archives of Internal Medicine, 112, 222-225.
https://doi.org/10.1001/archinte.1963.03860020120016
[8]  Edwards, J.K. (2015) Sickle Cell Trait Increases the Risk of Chronic Kidney Disease. Nature Reviews Nephrology, 11, 65.
https://doi.org/10.1038/nrneph.2014.229
[9]  Folsom, A.R., et al. (2015) Prospective Study of Sickle Cell Trait and Venous Thromboembolism Incidence. Journal of Thrombosis and Haemostasis, 13, 2-9.
https://doi.org/10.1111/jth.12787
[10]  Goodman, J., Hassell, K., Irwin, D., Witkowski, E.H. and Nuss, R. (2014) The Splenic Syndrome in Individuals with Sickle Cell Trait. High Altitude Medicine & Biology, 15, 468-471.
https://doi.org/10.1089/ham.2014.1034
[11]  Harrelson, G.L., Fincher, A.L. and Robinson, J.B. (1995) Acute Exertional Rhabdomyolysis and Its Relationship to Sickle Cell Trait. Journal of Athletic Training, 30, 309-312.
[12]  Jones, S.R., Binder, R.A. and Donowho, E.M. (1970) Sudden Death in Sickle-Cell Trait. The New England Journal of Medicine, 282, 323-325.
https://doi.org/10.1056/NEJM197002052820607
[13]  Crossan, A., Sandler, S. and Yao, W.J. (2014) The Prevalence of Primary Open Angle Glaucoma among Sickle Cell Patients in the Bronx. Investigative Ophthalmology & Visual Science, 55, Article 4275.
[14]  Tsaras, G., Owusu-Ansah, A., Boateng, F.O. and Amoateng-Adjepong, Y. (2009) Complications Associated with Sickle Cell Trait: A Brief Narrative Review. The American Journal of Medicine, 122, 507-512.
https://doi.org/10.1016/j.amjmed.2008.12.020
[15]  Allison, A.C. (1954) Protection Afforded by Sickle-Cell Trait against Subtertian Malarial Infection. The BMJ, 1, 290.
https://doi.org/10.1136/bmj.1.4857.290
[16]  (2023) Sickle Cell Research Priorities.
https://www.hematology.org/research/sickle-cell-disease-and-sickle-cell-trait/sickle-cell-research-priorities
[17]  Power-Hays, A. and McGann, P.T. (2020) When Actions Speak Louder than Words— Racism and Sickle Cell Disease. The New England Journal of Medicine, 383, 1902-1903.
https://doi.org/10.1056/NEJMp2022125
[18]  Schmidt, R.M. (1974) Hemoglobinopathy Screening: Approaches to Diagnosis, Education and Counseling. American Journal of Public Health, 64, 799-804.
https://doi.org/10.2105/AJPH.64.8.799
[19]  Pauling, L. and Itano, H.A. (1949) Sickle Cell Anemia a Molecular Disease. Science, 110, 543-548.
https://doi.org/10.1126/science.110.2865.543
[20]  Benson, J.M. and Therrell, B.L. (2010) History and Current Status of Newborn Screening for Hemoglobinopathies. Seminars in Perinatology, 34, 134-144.
https://doi.org/10.1053/j.semperi.2009.12.006
[21]  Treadwell, M.J., McClough, L. and Vichinsky, E. (2006) Using Qualitative and Quantitative Strategies to Evaluate Knowledge and Perceptions about Sickle Cell Disease and Sickle Cell Trait. Journal of the National Medical Association, 98, 704-710.
[22]  McGann, P.T. and Hoppe, C. (2017) The Pressing Need for Point-of-Care Diagnostics for Sickle Cell Disease: A Review of Current and Future Technologies. Blood Cells, Molecules, and Diseases, 67, 104-113.
https://doi.org/10.1016/j.bcmd.2017.08.010
[23]  Day, S.W., Brunson, G.E. and Wang, W.C. (1997) Successful Newborn Sickle Cell Trait Counseling Program Using Health Department Nurses. Pediatric Nursing, 23, 557-561.
[24]  Schultz, C. (2022) Stakeholder Interview with Dr. Corinna Schultz. Personal Interview.
[25]  Taylor, C., Kavanagh, P. and Zuckerman, B. (2014) Sickle Cell Trait—Neglected Opportunities in the Era of Genomic Medicine. JAMA, 311, 1495-1496.
https://doi.org/10.1001/jama.2014.2157
[26]  Harmon, K.G., Drezner, J.A., Klossner, D. and Asif, I.M. (2012) Sickle Cell Trait Associated with a RR of Death of 37 Times in National Collegiate Athletic Association Football Athletes: A Database with 2 Million Athlete-Years as the Denominator. British Journal of Sports Medicine, 46, 325-330.
https://doi.org/10.1136/bjsports-2011-090896
[27]  Stapley, E., O’Keeffe, S. and Midgley, N. (2022) Developing Typologies in Qualitative Research: The Use of Ideal-type Analysis. International Journal of Qualitative Methods, 21.
https://doi.org/10.1177/16094069221100633
[28]  Arksey, H. and O’Malley, L. (2005) Scoping Studies: Towards a Methodological Framework. International Journal of Social Research Methodology, 8, 19-32.
https://doi.org/10.1080/1364557032000119616
[29]  (2023) Sickle Cell Trait Screening.
https://www.redcrossblood.org/donate-blood/blood-types/diversity/african-american-blood-donors/sickle-cell-trait-screening.html
[30]  Kidney Cancer Association (2024) Know and Tell.
https://www.kidneycancer.org/know-and-tell/
[31]  Sickle Cell Disease Foundation (2024) Hemoglobin Trait Follow-Up Program.
https://www.scdfc.org/hemoglobin-trait-follow-up-program
[32]  Sickle Cell Disease Association of America Inc (2024) Frequently Asked Questions about SCT in Newborn Screening.
https://www.sicklecelldisease.org/2022/09/30/frequently-asked-questions-about-sct-in-newborn-screening/
[33]  Rudel, R.K., Byhoff, E., Strombotne, K.L., Drainoni, M.L. and Greece, J.A. (2023) Healthcare-Based Food Assistance Programmes in the United States: A Scoping Review and Typology. Journal of Nutritional Science, 12, e128.
https://doi.org/10.1017/jns.2023.111
[34]  Glaser, B.G. (1965) The Constant Comparative Method of Qualitative Analysis. Social Problems, 12, 436-445.
https://doi.org/10.2307/798843
[35]  Gallo, A.M., et al. (2016) Reproductive Health CHOICES for Young Adults with Sickle Cell Disease or Trait: Randomized Controlled Trial Outcomes over Two Years. Journal of Genetic Counseling, 25, 325-336.
https://doi.org/10.1007/s10897-015-9874-0
[36]  Creary, S., et al. (2017) Sickle Cell Trait Knowledge and Health Literacy in Caregivers Who Receive In-Person Sickle Cell Trait Education. Molecular Genetics & Genomic Medicine, 5, 692-699.
https://doi.org/10.1002/mgg3.327
[37]  Abrams, M.A., et al. (2022) A Health Literate Approach to Address Health Disparities: A Virtual Program for Parents of Children with Sickle Cell Trait. Journal of Communication in Healthcare, 15, 112-120.
https://doi.org/10.1080/17538068.2022.2026056
[38]  Beeman, C., et al. (2021) Closing Knowledge Gaps among Parents of Children with Sickle Cell Trait. Blood, 138, 2980.
https://doi.org/10.1182/blood-2021-151004
[39]  Acharya, K., Lang, C.W. and Ross, L.F. (2009) A Pilot Study to Explore Knowledge, Attitudes, and Beliefs about Sickle Cell Trait and Disease. Journal of the National Medical Association, 101, 1163-1172.
https://doi.org/10.1016/S0027-9684(15)31113-5
[40]  Sims, A.M., et al. (2022) Parents’ Experiences and Needs Regarding Infant Sickle Cell Trait Results. Pediatrics, 149, e2021053454.
https://doi.org/10.1542/peds.2021-053454
[41]  Collins, J.L., et al. (2013) Factors That Influence Parents’ Experiences with Results Disclosure after Newborn Screening Identifies Genetic Carrier Status for Cystic Fibrosis or Sickle Cell Hemoglobinopathy. Patient Education and Counseling, 90, 378-385.
https://doi.org/10.1016/j.pec.2011.12.007
[42]  Yang, Y.M., Andrews, S., Peterson, R., Shah, A. and Cepeda, M. (2000) Prenatal Sickle Cell Screening Education Effect on the Follow-Up Rates of Infants with Sickle Cell Trait. Patient Education and Counseling, 39, 185-189.
https://doi.org/10.1016/S0738-3991(99)00022-1
[43]  Housten, A.J., Abel, R.A., Lindsey, T. and King, A.A. (2016) Feasibility of a Community-Based Sickle Cell Trait Testing and Counseling Program. Journal of Health Disparities Research and Practice, 9, Article 1.
[44]  (2023) Implementation of the NCAA Sickle Cell Trait Screening Policy: A Survey of Athletic Staff and Student-Athletes—ClinicalKey.
https://doi.org/10.1016/j.jnma.2018.03.004
[45]  O’Connor, F.G., et al. (2012) ACSM and CHAMP Summit on Sickle Cell Trait: Mitigating Risks for Warfighters and Athletes. Medicine & Science in Sports & Exercise, 44, 2045-2056.
https://doi.org/10.1249/MSS.0b013e31826851c2
[46]  Webber, B.J. and Witkop, C.T. (2014) Screening for Sickle-Cell Trait at Accession to the United States Military. Military Medicine, 179, 1184-1189.
https://doi.org/10.7205/MILMED-D-14-00089
[47]  Bonham, V.L., Dover, G.J. and Brody, L.C. (2010) Screening Student Athletes for Sickle Cell Trait—A Social and Clinical Experiment. The New England Journal of Medicine, 363, 997-999.
https://doi.org/10.1056/NEJMp1007639
[48]  Lawrence, R.H. and Shah, G.H. (2014) Athletes’ Perceptions of National Collegiate Athletic Association-Mandated Sickle Cell Trait Screening: Insight for Academic Institutions and College Health Professionals. Journal of American College Health, 62, 343-350.
https://doi.org/10.1080/07448481.2014.902840
[49]  Tarini, B.A., Brooks, M.A. and Bundy, D.G. (2012) A Policy Impact Analysis of the Mandatory NCAA Sickle Cell Trait Screening Program. Health Services Research, 47, 446-461.
https://doi.org/10.1111/j.1475-6773.2011.01357.x
[50]  Manley, A.F. (1984) Legislation and Funding for Sickle Cell Services, 1972-1982. The American Journal of Pediatric Hematology/Oncology, 6, 67-71.
[51]  As One Foundation (2024) Operation Hydration.
https://asonefoundation.org/about-operation-hydration/
[52]  23andMe (2024) Sickle Cell Carrier Status Awareness Program.
https://www.23andme.com/sickle-cell/
[53]  Schultz, C.L., et al. (2022) Pediatricians’ Disclosure and Documentation of Sickle Cell Trait Found on Newborn Screening: Barriers and Possible Implementation Strategies. Blood, 140, 10875-10876.
https://doi.org/10.1182/blood-2022-170229
[54]  Lin, K.H., Granka, J.M., Shastri, A., Bonham, V.L. and Naik, R.P. (2022) Association of Sickle Cell Trait and Venous Thromboembolism in the 23andMe Cohort. Blood, 140, 1962.
https://doi.org/10.1182/blood-2022-163883
[55]  Cunnington, S., Codner, A., Nelson, E., McGrath, D. and Greece, J.A. (2023) The Shifting Public Health Landscape and Virtual Learning Environment: The Effectiveness of Practice-Based Teaching Delivered In-Person, Virtual, and Hybrid. International Journal of Environmental Research and Public Health, 20, Article 2867.
https://doi.org/10.3390/ijerph20042867
[56]  Curran, G.M., Bauer, M., Mittman, B., Pyne, J.M. and Stetler, C. (2012) Effectiveness-Implementation Hybrid Designs. Medical Care, 50, 217-226.
https://doi.org/10.1097/MLR.0b013e3182408812
[57]  CDC: Centers for Disease Control and Prevention. (2023) Learn More about Sickle Cell Disease.
https://www.cdc.gov/ncbddd/sicklecell/index.html
[58]  Okpala, I., et al. (2002) The Comprehensive Care of Sickle Cell Disease. European Journal of Haematology, 68, 157-162.
https://doi.org/10.1034/j.1600-0609.2002.01523.x
[59]  (1987) Newborn Screening for Sickle Cell Disease and Other Hemoglobinopathies. JAMA, 258, 1205-1209.
https://doi.org/10.1001/jama.258.9.1205
[60]  Ammerman, A., Smith, T.W. and Calancie, L. (2014) Practice-Based Evidence in Public Health: Improving Reach, Relevance, and Results. Annual Review of Public Health, 35, 47-63.
https://doi.org/10.1146/annurev-publhealth-032013-182458
[61]  Pope, J.P., Pelletier, L. and Guertin, C. (2018) Starting off on the Best Foot: A Review of Message Framing and Message Tailoring, and Recommendations for the Comprehensive Messaging Strategy for Sustained Behavior Change. Health Communication, 33, 1068-1077.
https://doi.org/10.1080/10410236.2017.1331305
[62]  Butler, M., et al. (2023) Improving Cultural Competence to Reduce Health Disparities. AHRQ Comparative Effectiveness Reviews. Agency for Healthcare Research and Quality (US), Rockville.
http://www.ncbi.nlm.nih.gov/books/NBK361126/
[63]  de Vere Hunt, I. and Linos, E. (2022) Social Media for Public Health: Framework for Social Media-Based Public Health Campaigns. Journal of Medical Internet Research, 24, e42179.
https://doi.org/10.2196/42179

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413